L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles
McDonagh, Birgitte Hjelmeland; Singh, Gurvinder; Hak, Sjoerd; Bandyopadhyay, Sulalit; Augestad, Ingrid Lovise; Peddis, Davide; Sandvig, Ioanna; Sandvig, Axel; Glomm, Wilhelm
Peer reviewed, Journal article
Accepted version
View/ Open
Date
2016Metadata
Show full item recordCollections
- Publikasjoner fra CRIStin - SINTEF AS [5867]
- SINTEF Industri [1571]
Abstract
Manganese oxide nanoparticles (MONPs) are capable of time‐dependent magnetic resonance imaging contrast switching as well as releasing a surface‐bound drug. MONPs give T2/T2* contrast, but dissolve and release T1‐active Mn2+ and L‐3,4‐dihydroxyphenylalanine. Complementary images are acquired with a single contrast agent, and applications toward Parkinson's disease are suggested.